--- title: "Advanced Biomed (ADVB.US) — Financial Reports" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/ADVB.US/norm.md" symbol: "ADVB.US" name: "Advanced Biomed" parent: "https://longbridge.com/en/quote/ADVB.US.md" datetime: "2026-03-16T23:46:29.030Z" locales: - [en](https://longbridge.com/en/quote/ADVB.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/ADVB.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/ADVB.US/norm.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/ADVB.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ADVB.US/norm.md) # Advanced Biomed (ADVB.US) — Financial Reports ## Income Statement (USD) | Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | EPS | 6.34 | -0.3576 | -0.6486 | -1.35 | -0.9079 | | ROE | 448.65% | -47.75% | -73.78% | -233.13% | -270.66% | | Revenue | - | - | - | - | - | | Net income | 6.86M | -386901.00 | -701611.00 | -1.38M | -907904.00 | | Operating income | -396642.00 | -523914.00 | -1.21M | -762739.00 | -280064.00 | | Gross margin | - | - | - | - | - | | Net margin | - | - | - | - | - | | Profit quality | - | - | - | - | - | ## Balance Sheet (USD) | Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | A&L | 10.85M | 6.24M | 6.51M | 8.29M | 4.50M | | Leverage | 1.14 | 2.08 | 1.87 | 2.01 | 7.28 | | BVPS | 8.76 | 2.78 | 3.21 | 3.82 | 0.6190 | | Turnover | - | - | - | - | - | | Cash & STI | 2.60M | 2.66M | 2.90M | 5.18M | 2.66M | | Inv & Rec | - | - | - | - | - | | LT assets | 118191.00 | 324067.00 | 396745.00 | 536125.00 | 642274.00 | | Net debt | -1.89M | -954641.00 | -1.64M | -3.12M | -747157.00 | ## Cash Flow Statement (USD) | Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | Operating CF | - | -610342.00 | -1.54M | -3.41M | - | | Investing CF | - | -1771.00 | -20149.00 | -2215.00 | - | | Financing CF | - | 447462.00 | -765466.00 | 5.90M | - | | Free CF | - | -573165.00 | -1.62M | -2.35M | - | | OCF coverage | - | -4696.02% | -180.01% | -153931.02% | - | | Repaid & issued | - | 458688.00 | 180686.00 | 262956.00 | - | | CapEx | - | -1771.00 | -20149.00 | -2215.00 | - |